Moreover, silencing of TRIM11 has suppressed the activation of the phosphatidylinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathway in hepatocellular and ovarian cancer cells, respectively [8, 9]. This evidence concerns the gene AKT1 and ovarian cancer.